St Louis Trust’s Bristol-Myers Squibb BMY Stock Holding History

St Louis Trust’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.01M	Hold	33,158	–	–	0.23%	52
2025 Q4	$1.79M	Hold	33,158	–	–	0.21%	59
2025 Q3	$1.5M	Hold	33,158	–	–	0.19%	55
2025 Q2	$1.53M	Hold	33,158	–	–	0.2%	50
2025 Q1	$2.02M	Buy	33,158 +3,451	+12%	+$201K	0.29%	46
2024 Q4	$1.68M	Hold	29,707	–	–	0.24%	53
2024 Q3	$1.54M	Sell	29,707 -3,451	-10%	-$162K	0.22%	54
2024 Q2	$1.38M	Hold	33,158	–	–	0.21%	56
2024 Q1	$1.8M	Buy	33,158 +3,451	+12%	+$176K	0.28%	50
2023 Q4	$1.52M	Hold	29,707	–	–	0.26%	50
2023 Q3	$1.72M	Hold	29,707	–	–	0.32%	47
2023 Q2	$1.9M	Hold	29,707	–	–	0.35%	45
2023 Q1	$2.06M	Hold	29,707	–	–	0.41%	41
2022 Q4	$2.14M	Buy	29,707 +1,305	+5%	+$98.4K	0.45%	41
2022 Q3	$1.76M	Sell	28,402 -1,305	-4%	-$94.7K	0.5%	33
2022 Q2	$2.29M	Hold	29,707	–	–	0.49%	37
2022 Q1	$2.17M	Hold	29,707	–	–	0.46%	39
2021 Q4	$1.85M	Buy	29,707 +1,305	+5%	+$76.6K	0.39%	44
2021 Q3	$1.68M	Sell	28,402 -2,497	-8%	-$164K	0.44%	39
2021 Q2	$2.06M	Hold	30,899	–	–	0.51%	35
2021 Q1	$1.95M	Hold	30,899	–	–	0.48%	34
2020 Q4	$1.92M	Hold	30,899	–	–	0.55%	28
2020 Q3	$1.86M	Hold	30,899	–	–	0.6%	26
2020 Q2	$1.82M	Hold	30,899	–	–	0.54%	25
2020 Q1	$1.72M	Hold	30,899	–	–	0.65%	22
2019 Q4	$1.98M	Hold	30,899	–	–	0.56%	23
2019 Q3	$1.57M	Sell	30,899 -845	-3%	-$39.7K	0.49%	28
2019 Q2	$1.44M	Hold	31,744	–	–	0.46%	29
2019 Q1	$1.51M	Hold	31,744	–	–	0.49%	29
2018 Q4	$1.65M	Hold	31,744	–	–	0.6%	22
2018 Q3	$1.97M	Hold	31,744	–	–	0.67%	26
2018 Q2	$1.76M	Hold	31,744	–	–	0.59%	28
2018 Q1	$2.01M	Sell	31,744 -1,352	-4%	-$87K	0.69%	28
2017 Q4	$2.03M	Hold	33,096	–	–	0.8%	19
2017 Q3	$2.11M	Hold	33,096	–	–	0.94%	18
2017 Q2	$1.84M	Hold	33,096	–	–	0.85%	19
2017 Q1	$1.8M	Hold	33,096	–	–	0.77%	19
2016 Q4	$1.94M	Sell	33,096 -80	-0.2%	-$4.37K	0.92%	16
2016 Q3	$1.79M	Sell	33,176 -624	-2%	-$40.1K	0.86%	18
2016 Q2	$2.49M	Sell	33,800 -5,152	-13%	-$364K	1.32%	15
2016 Q1	$2.49M	Buy	38,952 +4,557	+13%	+$287K	1.36%	17
2015 Q4	$2.37M	Buy	+34,395	New	+$2.27M	1.49%	13

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

St Louis Trust's BMY Position: Q1 2026 in Review

St Louis Trust held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 33,158 shares worth $2.01M. The position accounts for 0.23% of the portfolio, ranked #52.

St Louis Trust first reported a position in BMY in Q4 2015 and has held it in 42 quarters since. The position peaked at $2.49M in Q1 2016. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

St Louis Trust held 33,158 shares of Bristol-Myers Squibb worth $2.01M as of Q1 2026.
St Louis Trust left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.23% of St Louis Trust's portfolio in Q1 2026, its #52 holding.
St Louis Trust first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 42 quarters since.
St Louis Trust's Bristol-Myers Squibb position peaked at $2.49M in Q1 2016.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on St Louis Trust's 13F filing for Q1 2026, filed 14 May 2026.